Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ·Healthcare·Biotechnology
$0.35
—
Mkt Cap $3.01M
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$0.35
—
Mkt Cap $3.01M
Buy
5
Hold
2
Sell
0
Price Target (— analysts)
—
Range — – —